Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Zulekha Hospital LLC - [ DUBAI ] Print Dt : 19-01-21 11:20

Patient Investigation Report Page 1 of 2

Name : SHANKARBABU VEERAVNIYAN Age/Sex : 38Y8M27D/M Nationality : INDIA

PIN : ZH00448739 Visit Trn. No : 4401337 Sample No. : 2279778 Doctor :VIPIN MISHRA

*2279778*

Biological Reference
Investigation Findings Unit Method.
Interval

GLUCOSE (RANDOM) SERUM


GLUCOSE RANDOM 113 mg/dl 70-139 Enzymatic,Hexok

NB: Glucose test result may be higher than the reference range if sample was given within 2 hours after taking meal
Sample collected: 19/01/21 09:23 Received. 19/01/21 09:41 Reported. 19/01/2021 11:17

Technician Name : GEETAJ

GLYCOSYLATED HAEMOGLOBIN (EDTA WHOLE BLOOD)


GLYCOSYLATED H 6.6 % 4.0 - 5.6 Turbidimetric Imm
HEMOGLOBIN (HBA1C %)
Pre diabetes Risk: 5.7 -6.4%
Diabetes: > 6.5 %
Estimated Average Glucose (eAG) Formula (in mg/dl): (28.7 x HbA1c) - 46.7
References: American Diabetes Associaiton (ADA) recommendations
Sample collected: 19/01/21 09:23 Received. 19/01/21 09:41 Reported. 19/01/2021 11:17

Technician Name : GEETAJ

FREE T4 SERUM
FT4 H 26.3 pmol/L 12.0 - 22.0 ECLIA

Note: Patients receiving Biotin therapy/supplement with high doses (i.e. More than 5 mg per day) may have interference with
some immunoassays. Sample collection at least 8 hours following the last biotin administration is recommended.
Sample collected: 19/01/21 09:23 Received. 19/01/21 09:41 Reported. 19/01/2021 11:17

Technician Name : GEETAJ

THYROID STIMULATING HORMONE SERUM


TSH SERUM 2.04 uIU/ml 0.27 - 4.20 ECLIA

Note: Patients receiving Biotin therapy/supplement with high doses (i.e. More than 5 mg per day) may have interference with
some immunoassays. Sample collection at least 8 hours following the last biotin administration is recommended.
Sample collected: 19/01/21 09:23 Received. 19/01/21 09:41 Reported. 19/01/2021 11:17

Technician Name : GEETAJ

This report belongs to Zulekha Hospitals/Medical Center.Reproduction of this report partially or totally is strictly not permitted.
Zulekha Hospital LLC - [ DUBAI ] Print Dt : 19-01-21 11:20

Patient Investigation Report Page 2 of 2

Name : SHANKARBABU VEERAVNIYAN Age/Sex : 38Y8M27D/M Nationality : INDIA

PIN : ZH00448739 Visit Trn. No : 4401337 Sample No. : 2279778 Doctor :VIPIN MISHRA

*2279778*

Biological Reference
Investigation Findings Unit Method.
Interval

*** End Of Report ***


H - High, L - Low, HH - Cri High, LL - Cri Low

This report belongs to Zulekha Hospitals/Medical Center.Reproduction of this report partially or totally is strictly not permitted.

You might also like